Interface Biologics Information

View Top Employees from Interface Biologics

Interface Biologics is a commercial stage privately held company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices. IBI’s primary technology focus areas are anti-thrombogenic additives that reduce thrombosis in blood contacting medical devices and polymer enabled drug delivery devices.

Website	http://www.interfacebiologics.com
Revenue	$5 million
Funding	$5 million
Employees	6 (1 on RocketReach)
Founded	2001
Address	Mars Centre,south Tower, 101 College Street, Suite 300, Ontario,, Toronto, Ontario M5G 1L7, CA
Phone	+1 416-977-1329
Fax	(416) 977-1329
Technologies	JavaScript , HTML , Twitter +14 more (view full list)
Industry	Biotechnology, Biotechnology Research, Medical Devices & Equipment, Manufacturing, Science and Engineering, Drug Delivery, Health Care, Medical Device
Web Rank	10 Million
Keywords	Biomedical Polymers, Medical Devices, Medical Device Technology, Medical Technology, Polymer Technology, Biotechnology, Healthcare Technology, Biomaterials, Biomedical Materials, Biomedical Engineering, Polymer Science, Materials Science, Thrombosis Prevention, Drug Delivery, Additive Manufacturing, Regenerative Medicine, 3d Printing, Tissue Engineering, Pharmaceutical
Competitors	Johnson & Johnson, Medtronic, Abbott, Stryker, Cardinal Health, Boston Scientific, Cook Medical, B. Braun Group, Cameron Health, Terumo +39 more (view full list)
SIC	SIC Code 384 Companies, SIC Code 38 Companies
NAICS	NAICS Code 33 Companies, NAICS Code 339 Companies